View in EDS

199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis.

Saved in:
Bibliographic Details
Title: 199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis.
Authors: Szabados, B.E.1, Rodriguez-Vida, A.2, Duran, I.3, Crabb, S.J.4, van der Heijden, M.S.5, Pous, A. Font6, Gravis, G.7, Herranz, U. Anido8, Protheroe, A.9, Ravaud, A.10, Maillet, D.11, Mendez, M.J.12, Suarez, C.13, Linch, M.14, Prendergast, A.15, Tyson, C.16, Mousa, K.15, Castellano, D.17, Powles, T.B.18
Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1319-S1319. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.10.211